ABSTRACT-With flow cytometry, we investigated the effect of basic fibroblast growth factor (bFGF)-induced competence in subcultured endothelial cells (EC) (4-9-passage) of rat thoracic aorta. The cell population in each phase of the cell cycle was determined by a double staining technique with fluorescein isothiocyanate-conjugated mouse monoclonal antibody against the proliferation-associated nucleus antigen Ki-67 and propidium iodide for total DNA content. EC were cultured in medium containing 5% fetal bo vine serum (FBS) for 6 days. After serum-starvation for 2 days, the treatment with bFGF (3-10 ng/ml) for 12 hr promoted the entry of cells into the G1 phase from the G0 phase concentration-dependently.
Abnormal proliferation of vascular endothelial cells (EC) causes many diseases such as diabetic retinopathy (1) and atherosclerosis (2). Development of these angio genic diseases are reported to be induced several growth factors such as basic fibroblast growth factor (bFGF), platelet-derived growth factor and interleukin-8 (3 5). Growth factors are classified into two types, a compe tence factor and a progression factor, based on their modes of enhancement of cell proliferation (6). The com petence factors advance the cell cycle from the Go to G1 phase, whereas the progression factors promote entrance to the S phase from the G1 phase (7). bFGF, a compe tence factor not a progression factor, can induce DNA synthesis only in combination with a progression factor containing platelet-poor plasma in Balb/3T3 fibroblast (7). bFGF is also a potent mitogen for EC proliferation since the bFGF effect is enhanced in an autocline manner in vitro (8). In the previous study, we demonstrated that bFGF hastens the starting time of [3H]-thymidine incor poration into subcultured EC of rat aorta, suggesting the competence effect of bFGF (9). However, it remains to be determined if bFGF is a competence factor in EC as well as in fibroblasts.
A proliferation-associated nucleus antigen, Ki-67, is a useful tool for detecting the transition from the Go to G1 phase, because this antigen is expressed in actively grow ing cells but not in Go-arrested (quiescent) cells (10, 11). In the present study using flow cytometry with double staining of Ki-67 antigen and total DNA, we provided evidence that bFGF stimulates the competence in quies cent EC of rat thoracic aorta.
MATERIALS AND METHODS

Cell culture
Rat aortic EC in primary culture were prepared by the method reported by Schwartz (12) and Nagaura et al. (9) as follows: The thoracic aorta of male Wistar rats (9 week-old, 243 302 g; SLC, Tokyo) was isolated, and the periadventitial connective tissue was carefully removed. The vessel was placed into a culture dish (100-mm diam eter) filled with 10 ml Hanks' balanced salt solution (136.8 mM NaCI, 5.4 mM KCI, 0.8 mM MgSO4, 1.3 mM CaC12, 0.3 mM Na2HPO4i 5.6 mM glucose and 4.2 mM NaHCO3; pH 7.3) and cannulated with a needle. The needle was fastened with a thread, and the other end of the vessel lumen was closed with a vascular clamp. Hanks' balanced salt solution containing 2 mg/ml col lagenase (Wako, Osaka) was injected into the vessel from the needle and incubated for 30 min at 37C. Then the collagenase solution was washed out by 5 -10 ml Dul becco's modified Eagle medium (DMEM; Nissui, Tokyo) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Summit, Fort Collins, CO, USA), 160 U/ml penicillin G potassium (Banyu Seiyaku, Tokyo) and 100 [cg/ml streptomycin sulfate (Meiji Seika, Tokyo) and 4.2 mM NaHCO3. The cell-suspended medium was collected and added onto a Type I collagen (Koken, Tokyo)-coat ed, 24-well plate (Corning 258201; Iwaki Glass, Tokyo) at a density of 100 200 cells/0.5 ml/ 16-mm well. The cells were cultured in a humidified atmosphere of 5% CO2 in air at 37C. The non-endothelial cells such as smooth muscle cells or fibroblasts were removed with a rubber cleaner (Ikemoto Scientific Technology, Tokyo) under an optical microscope. The cloned EC were treated with Ca t+ and Mg2+-free phosphate-buffered saline (PBS) containing 0.5 mM EDTA and subcultured at a split ratio of 1 : 4. Subcultured EC were used at the 4th to 9th passage in each test. EC were identified by their typical cobblestone-like morphology and their ability to form tube-like structures in vitro (9, 13). Fig. 1 . Diagram for analysis of competence stimulation by basic fibroblast growth factor (bFGF) with [3H]-thymidine incor poration (above) and flow cytometry (below) in subcultured endothelial cells (EC) of rat aorta. Subcultured EC were seeded at a density of 1.5 x 105 cells/1.5 ml/collagen-coated 35-mm dish and incubated in 5% FBS-DMEM for 6 days. At the indicated time points, a-h, the EC were double-stained with fluorescein isothiocyanate (FITC)-conjugated Ki-67 monoclonal antibody and propidium iodide and then analyzed by flow cytometry. After a 6-day culture with 5% FBS and 2-day serum starvation, EC were treated for 12 hr with (A) or without bFGF (B), and then cultured with 1 % FBS. For investigating the effect of 10% FBS, EC were first treated for 12 hr with 10% FBS, subjected to serum starvation, and then cultured for a further 12-15 hr with 10% FBS (C).
Experimenta protocol Subcultured EC were seeded at a density of 1.5 x 105 cells/1.5 ml/collagen-coated 35-mm dish (Falcon 3001; Nippon Becton Dickinson, Tokyo) and incubated with 5 ° FBS-DMEM 6 days. In the case of flow cytometric analysis of cells during the exponential phase, EC at day 3 were used ( Fig. 1, A-a) . The subconfluent cells (6-day culture) were synchronized by serum starvation for 2 days ( Fig. 1, A-b) , and then the medium was exchanged with fresh serum-free DMEM containing bFGF (Fig. 1 , A-c: 3 and 10 ng/ml, Fig. 1 , B-e: 0 ng/ml) and applied to EC for 12 hr. Then the medium was washed out and replaced with 1016 FBS-DMEM to continue the culture further for 12-15 hr (Fig. 1, A-d and B-f ).
Flow cytometric analysis
In the previous paper (9), the competence effects of bFGF were investigated by analyzing the time course (day and hr) of [3H]-thymidine incorporation. Under the same experimental conditions, the EC were analyzed by flow cytometry. At the time points of 12 (before), 0 and 12-15 (after bFGF pretreatment for 12 hr) hr, the cells were harvested by treating them with PBS containing 0.5 mg/ml trypsin and 0.54 mM EDTA and then suspended in 10% FBS-DMEM. After washing them twice with PBS, 106 EC were fixed at -10 C to 8 C with 1 ml of periodate-lysine-paraformaidehyde solution for 15 min (14). The EC were washed twice with PBS, and they were centrifuged at 1800 x g for 5 min. The cell pellet was first stained at 4C for 1 hr with 10 p1 fluorescein isothiocya nate (FITC)-conjugated mouse anti-Ki-67 monoclonal antibody (mAb) (1 : 1 dilution, DAKO-Ki-67; Dako, Kyoto) for the proliferation-associated nucleus antigen. After washing out the antibody twice with PBS, the EC were secondly stained at 41C for 30 min with 1 ml PBS containing 50 pg/ml propidium iodide (PI; Molecular Probes, Eugene, OR, USA) and ribonuclease A (100 U/ml; Sigma Chemical, St. Louis, MO, USA) for total DNA content. FITC-conjugated mouse IgGI (Dako) was used as a negative control.
The doubly stained EC were analyzed by a Epics Elite flow cytometer (Coulter, Hialeah, FL, USA) equipped with an argon laser (the excitation wavelength at 488 nm). Green FITC fluorescence (520 530 nm) was measured using a 525-nm band pass filter, and red PI fluorescence
Materials
Recombinant human bFGF (154 amino-acid form, mo lecular weight of 17 kilodaltons, expressed in Escherichia coli and purified) was kindly supplied by Kaken Seiyaku (Kyoto). The 5% FBS-stimulated EC were composed of 69.2± 1.9% at the Go phase, 9.8±2.3% at the GI phase, 17.3 ± 1.1% at the S phase and 9.3±0.8% at the G2/M phase (n=5). For further explanations, see the legend for Fig. 1 .
RESULTS
Flow cytometric distribution pattern of rat aortic EC population in the cell cycle
After a 3 day-culture with 5076 FBS-DMEM, rat aortic EC were distributed at the Go, G1, S and G2/M phases of the cell cycle by gating analysis for red fluorescence of propidium iodide bound to DNA and green fluorescence of FITC bound to Ki-67 (Fig. 2) . The fluorescence of cells treated with FITC-conjugated Ki-67 mAb was within the region of 3 to 100 intensity of fluorescence (Fig. 2a) , whereas autofluorescence of cells treated with FITC-con jugated mouse IgGI was within the region of 0.1 to 3 in tensity of fluorescence (negative control in Fig. 2 ). The percentages of cells at each phase relative to the total number of EC were estimated to be 69.2± 1.9% at the Go phase, 9.8 ± 2.3 % at the G, phase, 17.3 ± 1.1 % at the S phase and 9.3±0.8% at the G2/M phase (n=5). Most of the EC belonging to the S and G2/M phases were Ki-67 negative. Competence effect of bFGF on rat aortic EC proliferation After a 6-day culture with 5010 FBS-DMEM, rat aortic EC were further cultured under serum-starvation for 2 days (Fig. 3b) . The percentages were 70.7 ±7.1 % at the Go phase, 20.9±7.4% at the GI phase, 7.9±7.4% at the S phase, 4.4± 1.2% at the G2/M phase (n=3). Then, the EC were stimulated for 12 hr without bFGF as a control culture (Fig. 3e) or with bFGF (3 ng/ml: Fig. 3c1 , 10 ng/ml: Fig. 3c2 ). At 0 hr (12 hr after the treatment without bFGF), the percentages were 82.9± 1.7010 at the Go phase, 10.8±2.2010 at the G1 phase, 6.9±0.6% at the S phase and 3.1±0.4% at the G2/M phase (Fig. 3e, con trol culture, n=4). The treatment with bFGF (10 ng/ml) for 12 hr slightly decreased the cells in the Go phase to 78.2±2.307o and significantly increased those in the G, phase to 15.6±2.5% (Fig. 3c2 and A-c, n=4 ). Few effects were observed at the S and G2/M phases. Similar effects were obtained by treatment with 3 ng/ml bFGF, although these effects were not significant.
After a further 12 to 15-hr culture with 1076 FBS after removing the above medium, the percentages were 80.9± 1.2070 at the Go phase, 11.0±0.8To at the G, phase, 8.4± 1.1070 at the S phase and 3.1±0.4076 at the G2/M phase (Fig. 3f, n=4) . Treatment with 10 ng/ml bFGF significantly increased the S phase cells to 9.0± 1.6070 and G2/M phase cells to 3.3±0.7070 (Fig. 3d2i n=5) . The per centages in EC precultured with 3 ng/ml bFGF were 76.6±2.4070 at the Go phase, 14.4± 1.2070 at the G, phase, 8.5 ± 1.6% at the S phase and 3.5 ± 1.1076 at the G2/M phase ( Fig. 3d], n=3 ). These results demonstrate that bFGF treatment stimulates cells to enter the G, phase from the Go phase by 5070. The transition from the Go to GI, S and G2/M phases was advanced more rapidly by 10 ng/ml bFGF than by 3 ng/ml bFGF. Quiescent (serum-starvated) EC (Fig. 4b) were cultured with 10% FBS for 12 hr (Fig. 4g, 0 time point) and for an additional 12 -15 hr (Fig. 4h) as a positive control for the above effect of bFGF. The percentages were 82.3 ± 3.9070 at the Go phase, 10.9 ± 3.4 at the G 1 phase, 7.0 ± 1.2% at the S phase and 3.0±0.4%
at the G2/M phase at 0-hr time point after 12-hr culture with 10010 FBS (Fig. 4g,  n=3 ). After the additional 12 to 15-hr treatment with 10010 FBS, the percentages were 75.8±4.1010 at the Go phase, 13.4_±:2.407o at the G, phase, 10.7--:L 1.5010 at the S phase and 4.6±0.9010 at the G2/M phase (Fig. 4h, n=4) . These results suggest that the quiescent EC were advanced to the G,, S, G2/M phases by 10% FBS. Thus, only a part of the EC-population was transferred by 10% FBS, as well as 3 10 ng/ml bFGF. DISCUSSION bFGF is localized in the nuclear chromatin, nucleoli, cytosol and cytoplasmic vesicles in subconfluent EC (15), and it may stimulate EC growth in an autocrine manner. The concept of the competence phenotype and the progression phenotype in the cell cycle has been proposed by Pledger et al. (6). It is very important to investigate the cell cycle in abnormally proliferating cells, which are de tected in angiogenic diseases. EC composed of a vascular lumen are normally in a quiescent state. However, angio genic stimuli can induce EC to sprout from a blood vessel and proliferate (16). In the previous study, we have devised a convenient competence assay to evaluate the effects of growth factors on the competence phase of cell proliferation with two indices, the starting time of [3H] thymidine incorporation and its incorporation rate; Our study indicated that the treatment with bFGF (1, 10 and 30 ng/ml) for 12 hr promotes initiation of [3H]-thymidine incorporation into aortic EC (17, 18). Furthermore, the present flow cytometric analysis demonstrated that the treatment with bFGF increased the population at the G, phase, compared with the control without bFGF. These results provide evidence that bFGF is a competence factor in rat aortic EC. It is considered that bFGF-induced competence may cause the abnormal proliferation of EC in angiogenic diseases.
In the previous flow cytometric analysis of smooth muscle cells from rat aorta, high levels of Ki-67 antigen expression are observed at the Go, G1, early, S and G2/M phases, whereas there was only a low level at the G,, late phase (19). In contrast, the Ki-67 expression in EC of rat aorta was negative level and hardly detected at Go, S and G2/M phases, despite high level at only G, phase. The same phenomena in bovine EC were reported by Antoine et al. (20) . These results suggest that the expression of other proteins in addition to Ki-67 proteins may also be involved in EC proliferation.
In conclusion, we provide evidence that bFGF stimu lates the entry of EC into the G, phase from the Go phase, as a competence factor.
